Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Guaifenesin 100mg/5ml oral solution
0309020G0AAABAB
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 142 |
|
Robitussin Chesty Cough 100mg/5ml oral solution
0309020G0BBACAB
|
Robitussin | Guaifenesin | Respiratory System | 113 |
|
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml soln
0309020G0AAAGAG
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 93 |
|
Guaifenesin 66.67mg/5ml oral solution sugar free
0309020G0AAAEAE
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 48 |
|
Benylin Mucus Cough Plus Decongestant syrup
0309020G0BNAFAG
|
Benylin (Guaifenesin) | Guaifenesin | Respiratory System | 37 |
|
Covonia Chesty Cough Sugar Free syrup
0309020G0BVAAAE
|
Covonia (Guaifenesin) | Guaifenesin | Respiratory System | 29 |
|
Benylin Chesty Coughs Non-Drowsy oral solution
0309020G0BNACAP
|
Benylin (Guaifenesin) | Guaifenesin | Respiratory System | 13 |
|
Robitussin Chesty Cough with Congestion liquid
0309020G0BBADAT
|
Robitussin | Guaifenesin | Respiratory System | 11 |
|
Benylin Mucus Cough Max Menthol 100mg/5ml oral solution
0309020G0BNAGAB
|
Benylin (Guaifenesin) | Guaifenesin | Respiratory System | 6 |
|
Guaifenesin 100mg/5ml / Levomenthol 1.1mg/5ml oral solution
0309020G0AAAPAP
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 6 |
|
Benylin Mucus Cough Max Honey & Lemon Flavour 100mg/5ml syr
0309020G0BNAHAB
|
Benylin (Guaifenesin) | Guaifenesin | Respiratory System | 4 |
|
Benylin Children's Chesty Coughs 50mg/5ml oral solution
0309020G0BNADAN
|
Benylin (Guaifenesin) | Guaifenesin | Respiratory System | 3 |
|
Guaifenesin 50mg/5ml oral solution
0309020G0AAALAL
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 3 |
|
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml soln SF
0309020G0AAATAT
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 1 |
|
Guaifenesin 50mg/5ml oral solution sugar free
0309020G0AAANAN
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 1 |
|
Guaifenesin 600mg modified-release tablets
1002020L0AAACAC
|
Guaifenesin (Systemic) | Guaifenesin | Musculoskeletal and Joint Diseases | 1 |
|
Adult Meltus Chesty Cough with Decongestant oral solution
0309020G0BJAFAG
|
Meltus (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Adult Meltus Chesty Coughs Sugar & Colour Free oral solution
0309020G0BJACAK
|
Meltus (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Adult Meltus for Chesty Coughs and Catarrh oral solution
0309020G0BJAEA0
|
Meltus (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Beechams Veno's for Kids Chesty Cough 33.33mg/5ml syrup
0309020G0BKAAAJ
|
Beechams Veno's for Kids | Guaifenesin | Respiratory System | No data available |
|
Bell's Mucus Cough 100mg/5ml oral solution
0309020G0BTAAAB
|
Bell's (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
|
Benylin Chesty Coughs oral solution 5ml sachets
0309020G0BNABAM
|
Benylin (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
|
Benylin Children's Chesty Coughs 50mg/5ml soln 5ml sachets
0309020G0BNAAA0
|
Benylin (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
|
Benylin Mucus Cough oral solution
0309020G0BNAEAP
|
Benylin (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
|
Boots Catarrh Cough syrup
0309020G0BHAFAT
|
Boots (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.